AbCellera Biologics Inc. (ABCL)
NASDAQ
Market Cap
$858.04M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
160 of 968
Rank in Industry
108 of 556
Largest Insider Buys in Sector
ABCL Stock Price History Chart
ABCL Stock Performance
About AbCellera Biologics Inc.
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Insider Activity of AbCellera Biologics Inc.
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $739,977 and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $37.55M and sold $394.03M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thermopylae Holdings Ltd. (10 percent owner) — $739,977.
The last purchase of 283,516 shares for transaction amount of $739,977 was made by Thermopylae Holdings Ltd. (10 percent owner) on 2024‑08‑29.
List of Insider Buy and Sell Transactions, AbCellera Biologics Inc.
| 2024-08-29 | 10 percent owner | 283,516 0.0993% | $2.61 | $739,977 | +5.93% | |||
| 2023-11-08 | director | 10,000 0.0037% | $4.46 | $44,600 | -3.75% | |||
| 2023-11-06 | director | 20,000 0.0071% | $4.64 | $92,800 | -9.70% | |||
| 2023-09-22 | director | 20,000 0.0066% | $4.91 | $98,200 | -12.40% | |||
| 2023-09-12 | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -14.30% | |||
| 2023-08-08 | director | 30,000 0.0104% | $5.90 | $177,000 | -22.03% | |||
| 2023-05-26 | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.32% | |||
| 2023-05-26 | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.32% | |||
| 2022-12-16 | director | 85,102 0.0295% | $10.10 | $859,249 | -33.50% | |||
| 2022-08-19 | 10 percent owner | 200,000 0.0702% | $11.46 | $2.29M | -19.58% | |||
| 2022-06-14 | 10 percent owner | 9,173 0.0029% | $8.05 | $73,842 | +16.48% | |||
| 2022-06-13 | 10 percent owner | 54,915 0.0189% | $8.03 | $441,066 | +25.00% | |||
| 2022-06-06 | 10 percent owner | 64,545 0.0222% | $7.50 | $483,965 | +33.64% | |||
| 2022-05-16 | Chief Operating Officer | 200,000 0.057% | $6.34 | $1.27M | +31.24% | |||
| 2022-05-13 | 10 percent owner | 300,000 0.1057% | $7.26 | $2.18M | +41.77% | |||
| 2022-05-12 | 10 percent owner | 1.41M 0.4723% | $6.41 | $9.02M | +52.76% | |||
| 2022-05-12 | Chief Financial Officer | 85,000 0.0258% | $5.79 | $492,150 | +52.76% | |||
| 2022-03-04 | director | 10,000 0.0035% | $8.54 | $85,400 | +20.22% | |||
| 2022-03-01 | director | 20,000 0.0071% | $9.05 | $181,000 | +13.38% | |||
| 2022-02-28 | Chief Operating Officer | 230,789 0.0808% | $8.66 | $2M | +17.68% |
Insider Historical Profitability
<0.0001%
| Thermopylae Holdings Ltd. | 10 percent owner | 56086009 18.9886% | $2.91 | 10 | 1 | +6.49% |
| THIEL PETER | director | 10179880 3.4465% | $2.91 | 1 | 0 | <0.0001% |
| Lecault Veronique | Chief Operating Officer | 2040122 0.6907% | $2.91 | 4 | 1 | <0.0001% |
| Hayden Michael R | director | 1323397 0.4481% | $2.91 | 3 | 1 | <0.0001% |
| Hansen Carl L. G. | Chief Executive Officer | 233500 0.0791% | $2.91 | 0 | 1 | |
| Booth Andrew | Chief Financial Officer | 153000 0.0518% | $2.91 | 3 | 1 | <0.0001% |
| HAMER JOHN | director | 128862 0.0436% | $2.91 | 0 | 2 | |
| Montalbano John S. | director | 86000 0.0291% | $2.91 | 6 | 0 | <0.0001% |
| Stimart Tryn | Chief Legal Officer | 250 0.0001% | $2.91 | 1 | 1 | <0.0001% |
| Falconer Ester | Chief Technology Officer | 0 0% | $2.91 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Baker Bros Advisors LP | $124.69M | 9.36 | 27.53M | +20.15% | +$20.91M | 0.9 | |
| Baillie Gifford Co | $105.01M | 7.88 | 23.18M | -3.6% | -$3.92M | 0.08 | |
| Voya Investment Management LLC | $48.16M | 3.62 | 10.63M | +0.07% | +$36,008.97 | 0.05 | |
| Capital World Investors | $37.83M | 2.84 | 8.35M | 0% | +$0 | 0.01 | |
| Credit Suisse | $20.6M | 1.55 | 4.55M | -0.68% | -$140,135.55 | 0.02 | |
| OrbiMed | $18.94M | 1.42 | 4.18M | 0% | +$0 | 0.15 | |
| Arrowmark Colorado Holdings Llc | $18.6M | 1.4 | 4.11M | 0% | +$0 | 0.05 | |
| BlackRock | $17.67M | 1.33 | 3.9M | -0.13% | -$23,324.97 | <0.0001 | |
| Founders Fund | $17.09M | 1.28 | 3.77M | 0% | +$0 | 88.05 | |
| Federated Hermes | $12.75M | 0.96 | 2.82M | -9.69% | -$1.37M | 0.03 | |
| Casdin Capital | $10.69M | 0.8 | 2.36M | 0% | +$0 | 0.53 | |
| LAZARD ASSET MANAGEMENT LLC | $9.15M | 0.69 | 2.02M | -40.8% | -$6.31M | 0.01 | |
| Prosight Management Lp | $8.11M | 0.61 | 1.79M | +5.29% | +$407,700.00 | 2.26 | |
| Guardian Capital Advisors LP | $7M | 0.61 | 1.79M | 0% | +$0 | 0.77 | |
| Two Sigma Advisers LP | $7.96M | 0.6 | 1.76M | +76.95% | +$3.46M | 0.01 | |
| Renaissance Technologies | $6.75M | 0.51 | 1.49M | +2.06% | +$136,354.99 | 0.01 | |
| Two Sigma | $6.71M | 0.5 | 1.48M | +38.5% | +$1.86M | 0.01 | |
| Millennium Management LLC | $5.74M | 0.43 | 1.27M | +1.02% | +$57,979.47 | <0.01 | |
| Novo Holdings A/S | $5.1M | 0.38 | 1.13M | 0% | +$0 | 0.36 | |
| Man Group Plc | $3.5M | 0.26 | 771,934 | New | +$3.5M | 0.01 | |
| Citadel Advisors LLC | $3.46M | 0.26 | 764,833 | +32.25% | +$844,967.19 | <0.01 | |
| Intellectus Partners | $2.45M | 0.18 | 541,783 | -38.94% | -$1.57M | 0.66 | |
| ExodusPoint Capital Management, LP | $2.25M | 0.17 | 496,012 | +271.12% | +$1.64M | 0.03 | |
| D. E. Shaw & Co. | $2.05M | 0.15 | 453,235 | +1,379.57% | +$1.91M | <0.01 | |
| State Street | $2.04M | 0.15 | 450,255 | -2.31% | -$48,221.85 | <0.0001 | |
| Founders Fund Growth Management Llc | $1.84M | 0.14 | 407,017 | 0% | +$0 | 2.94 | |
| Morgan Stanley | $1.77M | 0.13 | 390,139 | +3.52% | +$60,017.95 | <0.0001 | |
| Royal Bank of Canada | $1.78M | 0.13 | 392,357 | +1.09% | +$19,194.07 | <0.0001 | |
| JPMorgan Chase | $1.68M | 0.13 | 370,765 | -9.41% | -$174,377.77 | <0.0001 | |
| Ameriprise Financial | $1.31M | 0.1 | 289,836 | -0.02% | -$226.50 | <0.0001 | |
| Belmont Capital Group | $1.18M | 0.09 | 260,000 | -49.02% | -$1.13M | 0.32 | |
| Geode Capital Management | $1.17M | 0.09 | 257,366 | +0.48% | +$5,535.65 | <0.0001 | |
| Commonwealth Of Pennsylvania Public School Empls Retrmt Sys | $1.13M | 0.09 | 250,248 | 0% | +$0 | 0.01 | |
| PDT Partners | $1.12M | 0.08 | 247,478 | +0.04% | +$453.00 | 0.09 | |
| Susquehanna International Group | $1.01M | 0.08 | 222,058 | -33.91% | -$516,121.15 | <0.01 | |
| Jump Financial Llc | $1.01M | 0.08 | 221,913 | -10.37% | -$116,348.53 | 0.01 | |
| Goldman Sachs | $935,114.00 | 0.07 | 206,427 | -65.67% | -$1.79M | <0.0001 | |
| National Bank Of Canada Fi | $704,147.00 | 0.06 | 183,885 | +2,292.78% | +$674,718.99 | <0.01 | |
| Dimensional Fund Advisors | $808,863.00 | 0.06 | 178,557 | +88.81% | +$380,474.60 | <0.0001 | |
| Barclays | $780,000.00 | 0.06 | 172,358 | +42.85% | +$233,971.04 | <0.0001 | |
| Bank of America | $711,586.00 | 0.05 | 157,083 | -8.41% | -$65,381.49 | <0.0001 | |
| SEB | $682,069.00 | 0.05 | 150,567 | +64.79% | +$268,176.19 | <0.01 | |
| Toronto-Dominion Bank | $634,200.00 | 0.05 | 140,000 | 0% | +$0 | <0.01 | |
| Macquarie Group | $541,000.00 | 0.04 | 119,399 | 0% | +$0 | <0.0001 | |
| American Century Investments | $531,478.00 | 0.04 | 117,324 | -0.2% | -$1,046.43 | <0.0001 | |
| Polar Asset Management Partners Inc | $533,770.00 | 0.04 | 117,830 | 0% | +$0 | 0.01 | |
| Archpoint Investors | $521,199.00 | 0.04 | 115,055 | 0% | +$0 | 0.23 | |
| Stifel | $495,029.00 | 0.04 | 109,277 | -0.79% | -$3,932.07 | <0.01 | |
| Advisor Group Holdings Inc | $474,932.00 | 0.04 | 104,847 | +2.63% | +$12,180.53 | <0.01 | |
| UBS | $461,947.00 | 0.04 | 101,975 | +3,979% | +$450,621.99 | <0.0001 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.